CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA LLC

1:14-cv-01533

Overview

Case Number 1:14-cv-01533
Filing Date 2014-12-30
Status Terminated
Termination Date 2015-03-24
Court District Court, D. Delaware (ded)
Presiding Judge Leonard P. Stark
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Fresenius Kabi USA LLC

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Sanofi

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Aventis Pharma S.A.

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Sanofi-Aventis U.S. LLC

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Leonard P. Stark

Patents Involved

2 Patents

There are 2 patents involved in this case.

Docket Entries

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Fresenius Kabi USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1647673.) - filed by Sanofi-Aventis U.S. LLC, Aventis Pharma S.A., Sanofi. (Attachments: # 1 Exhibit A & B, # 2 Civil Cover Sheet)(dmp, ) (Entered: 12/31/2014)

2014-12-30
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 12/31/2014)

2014-12-30
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/19/2014. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 12/17/2017. (dmp, ) (Entered: 12/31/2014)

2014-12-30
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,847,170; 7,241,907 B2;. (dmp, ) (Entered: 12/31/2014)

2014-12-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc